The J2E erythroid cell line, transformed by retroviral v-raf/vmyc oncogenes, proliferates and differentiates in response to erythropoietin. Here we show that J2E cells undergo apoptosis rapidly after serum withdrawal and that only erythropoietin of seven growth factors tested, could protect the cells from death. The role of JAK2 and MAP kinases in transmitting viability signals initiated by erythropoietin was examined in these cells. Despite constituitive raf kinase activity, phosphorylation of MAP kinases fell after serum withdrawal. However, an antisense oligonucleotide strategy revealed that JAK2, but not the MAP kinases, was involved in transmitting signals to maintain the viability of J2E cells. Several cell cycle proteins and transcription factors were also studied; although c-jun rose sharply during apoptosis, erythropoietin could not suppress this increase. It was concluded that erythropoietin-induced protection from apoptosis involved JAK2, but not MAP kinases or c-jun.
Introduction
Erythropoiesis is regulated by the glycoprotein hormone erythropoietin (epo), which acts by binding to specific receptors on erythroid precursor cells, thereby promoting growth and differentiation into mature red blood cells (Krantz, 1991; Jelkmann, 1992; Koury and Bondurant, 1992) . The action of epo has been studied in primary cell cultures and transformed cell lines, and the signal transduction mechanism of the hormone is gradually being elucidated (Koury and Bondurant, 1992; Wojchowski and He, 1993; Ihle, 1995) . Various laboratories have reported that the processes of proliferation and differentiation in erythroid cells can be separated (Noguchi et al, 1988; Sytkowski et al, 1980 , Liboi et al, 1993 Busfield and Klinken, 1992) , which suggests that they are mediated by different pathways. It has also been demonstrated that epo is involved in preventing the death of erythroid precursors Bondurant, 1988, 1990; Spivak et al, 1991) . Studies on Friend virus-infected erythroid cells and the epo-dependent HCD-57 line have shown that epo retards DNA breakdown and maintains cell viability Bondurant, 1988, 1990; Spivak et al, 1991) . Our recent studies have indicated that distinct epo-induced signalling pathways may exist in cells which lead to cell division, maturation and maintenance of viability (Tilbrook et al, 1996a) . In addition, IL-2, IL-3 and GM ± CSF transmit signals that promote cell survival, independent of initiating cell division (Okuda et al, 1994; Inhorn et al, 1995; Kinoshita et al, 1995; Boise et al, 1995) .
Apoptosis is the term used to describe physiological cell death which may be initiated either by external signals, or by the lack of viability factors, and appears to be programmed by the cell (Kerr et al, 1972; Wyllie et al, 1980; Raff, 1992) . One of the characteristic features of cells undergoing apoptosis is nuclear condensation and fragmentation. These membrane-bound apoptotic bodies are clearly visible by light and electron microscopy. Additionally, DNA in apoptotic cells is degraded by endogenous endonucleases and typical nucleosomal banding patterns can be observed by gel electrophoresis (Koury and Bondurant, 1990; Williams et al, 1990; Spivak et al, 1991) .
In this report, we describe the susceptibility of the erythroid J2E cell line to apoptosis. This clonal population of cells was immortalized at the proerythroblast stage of development by infection with the J2 virus containing the vraf and v-myc oncogenes (Klinken et al, 1988) . The cells do not require epo for growth in culture, but respond to the hormone by proliferating and terminally differentiating (Klinken et al, 1988; Busfield and Klinken, 1992; Busfield et al, 1993a Busfield et al, ,b,c, 1995a Callus et al, 1995; Tilbrook et al, 1996a,b) . We show here that the J2E cells become committed to apoptosis 4 ± 6 h after withdrawal of fetal calf serum (FCS), and only epo, of seven growth factors tested, was able to inhibit cell death. Experiments with intracellular signalling molecules revealed that Janus kinase 2 (JAK2) plays an important role in epo signalling for cell viability, whereas mitogen activated protein (MAP) kinases do not appear to be involved in this process.
Results

J2E cells undergo apoptosis after serum withdrawal
As most cell lines require growth and viability factors present in FCS for survival, we investigated the effect of removing serum from J2E cultures. Figure 1a shows that the viability of J2E cells was dependent on the concentration of FCS ± below 5% FCS the viability of J2E cells fell dramatically. This decrease was time dependent, and could be reversed by reintroduction of FCS up to 4 h after serum deprivation ( Figure  1b) . Thereafter, fewer cells could be rescued and commitment to cell death appeared irrevocable. Significantly, DNA synthesis ceased within 3 h of FCS removal (data not shown).
To determine if the cells were undergoing programmed cell death, their morphology was examined after serum withdrawal. Cells were collected and stained with MayGrunwald-Geimsa and two DNA-binding flurochromes (Figure 2 ). Unlike normal J2E cells in culture, the serumstarved cells appeared smaller and contained fragmented nuclei (Figure 2a ). Fluorescence microscopy using acridine orange and H33258 revealed that the highly condensed fragments did indeed contain DNA (Figure 2b and c) . These data were confirmed by the strong correlation between the number of cells with degraded DNA, as identified by Apotag staining, and cells unable to exclude eosin (r=0.96).
To investigate this phenomenon in greater detail, electron microscopy was employed to view the cells at higher magnification. Figure 3 shows some normal J2E cells with large nuclei and diffuse chromatin structure; organelles such as mitochondria, endoplasmic reticulum and ribosomes are clearly visible. In contrast, other cells in these cultures displayed nuclear condensation and fragmentation, decreased cell volume and condensed membrane-bound organelles. These features are characteristic of cells undergoing apoptosis (Kerr et al, 1972; Wyllie et al, 1980; Raff, 1992) .
Another feature commonly associated with programmed cell death is the nucleosomal banding pattern of degrading DNA. When DNA was extracted from J2E cells and separated by gel electrophoresis, nucleosomal banding associated with DNA degradation increased markedly with time ( Figure 4 
J2E cells are more susceptible to apoptosis than MEL cells
The rate of cell death for J2E cells was compared with Friendvirus transformed murine erythroleukemic (MEL) cells because they are immortalized at similar stages of erythroid differentiation (Klinken et al, 1988; Dube et al, 1975) . However, unlike the J2E line, MEL cells do not differentiate in response to epo and mature only with xenobiotic stimulation (Marks and Rifkind, 1978) . Data presented in Table 1 show that the J2E cell died more rapidly following serum withdrawal than the MEL cells. Thus, the J2E cells appear to be inherently more sensitive to serum deprivation than a comparable erythroid cell line. In addition to dying when serum was removed, J2E cells also underwent apoptosis shortly after cultures became confluent (data not shown). In contrast, MEL cells grown in parallel were much more robust than J2E cells. One explanation for these observations is that J2E cells are susceptible to cell death whenever replication is impeded.
To determine if J2E cells would die when cell division was impeded, cultures were established at low cell density with ample FCS, then inhibited from proliferating by addition of aphidicolin, a drug which inhibits the cell cycle at the Figure 4 DNA degradation after serum withdrawal. J2E cultures were established without serum, then cells were collected at various times (0 ± 24 h) for DNA extraction and separation on agarose gels. Cultures of J2E and MEL cells were washed thoroughly and grown in serum-free media. The effect of epo (5 U/ml) on the viability of cells was determined over 24 h. Each value is the mean of three experiments (+SD). 
Epo prevents apoptosis of J2E cells
It has been suggested that epo plays a crucial role in maintaining the viability of erythroid cells Bondurant, 1988, 1990; Spivak et al, 1991) . In addition, a number of other factors including stem cell factor (SCF), interleukin 3 (IL-3), granulocyte-macrophage colony stimulating factor (GM ± CSF), insulin, insulin-like growth factor 1 (IGF-1) and growth hormone are thought to be involved in promoting the survival of immature erythroid cells. These factors were added to cultures depleted of FCS to determine whether they could support the viability of J2E cells. Figure 6a and Table 1 show that epo could maintain the viability of J2E cells in the absence of FCS, whereas the other factors provided no protection from apoptosis. Furthermore, epo was able to restrict DNA degradation in the absence of FCS (Figure 6b ). From these data we concluded that epo could act as a viability factor for these immature erythroid cells. In contrast, epo could not protect MEL cells from dying in the absence of serum (Table 1) . However, epo is not the molecule present in FCS which maintains the viability of J2E cells ( Figure 1b ) as no detectable epo is present in the serum (data not shown).
To determine if the concentration of epo required to maintain the survival of J2E cells was the same as that required for induction of cell division and differentiation, a dose response curve to the hormone was generated. Figure 7 shows that proliferation and maturation peaked between 0.1 and 0.3 U/ml epo, as we have described previously (Busfield and Klinken, 1992; Tilbrook et al, 1996b) . Significantly, maintenance of viability by epo occurred at almost exactly the same concentration. This indicated that cell survival was concentration dependent, and did not differ from the amount of epo necessary for proliferation and differentiation.
JAK2 is required for the epo survival signal
Immediately after binding its ligand the epo receptor dimerizes and the ancillary kinase JAK2 is activated, enabling signals to be transduced within the cell. Using antisense oligonucleotides we have shown elsewhere that JAK2 is essential, not
Epo protects J2E cells from apoptosis and DNA degradation. (a) J2E cells were washed thoroughly and replated in 10% FCS, no serum (7) or no serum plus 10 U/ml epo, IGF-1, growth hormone (GH), insulin (INS), IL-3, GM-CSF and SCF. Viabilities were determined 24 h later. (b) J2E cells were grown in the presence, or absence, of 10% FCS with, or without, 10 U/ml epo for 24 h before DNA was extracted and separated on agarose gels. only for epo-induced proliferation, but also for differentiation (Tilbrook et al, 1996b) . Here we tested the role of JAK2 in epo signalling for cell viability. Anti-sense oligonucleotides to JAK2 were added to J2E cultures and after 3 days JAK2 protein content was less than 10% of the original amount (Tilbrook et al, 1996b) . Serum was then withdrawn from the cultures and viability assessed. Table 2 shows that by blocking JAK2, the ability of epo to promote cell survival was significantly suppressed. In contrast, a control oligonucleotide had no effect on viability. These data demonstrate that JAK2 plays an important role in epo-initiated signal transduction pathways which prevent cell death.
Epo does not maintain viability via the MAP kinase pathway
As epo activates the ras/MAP kinase signal transduction pathway in J2E cells (Tilbrook et al, 1996a) , the effects of serum deprivation on raf and MAP kinases were investigated. Raf kinase was constitutively activated in J2E cells and the level of activity was maintained after FCS removal from culture ( Figure 8 ). This result was not surprising as J2E cells were transformed by the v-raf/v-myc containing J2 virus (Klinken et al, 1988) . Immunoblotting revealed that p42 and p44 MAP kinases were highly phosphorylated during normal cell growth (Figure 9 ), due in part to the elevated raf activity. However, upon serum withdrawal the phosphorylation status of the MAP kinases declined appreciably, despite raf kinase activity being maintained (Figures 8 and 9 ). As reintroduction of FCS activated the MAP kinases (Figure 9 ), it appears that FCS, and not just an activated raf gene, is needed to maintain MAP kinase activity.
We have shown elsewhere that MAP kinase activity is linked to epo-induced differentiation (Tilbrook et al, 1996a) , and others have demonstrated an association with the proliferative effects of epo (Miura et al, 1994; Todokoro et al, 1994; Bittorf et al, 1994; Gobert et al, 1995) . As MAP kinase phosphorylation decreased markedly after serum withdrawal, we speculated that it may also be involved in viability signalling. To this end the anti-sense oligonucleotide strategy employed by Sale et al (1995) was used to determine the role of p42 and p44 MAP kinases in epoinduced survival. Table 3 shows that, unlike JAK2, inhibition of the MAP kinases made no difference to the maintenance of viability supported by epo. In these experiments, MAP kinase protein content was reduced by more than 70% and differentiation was suppressed accordingly. These data indicate that the MAP kinase pathway is not involved in regulating cell survival and are consistent with a role in differentiation. Figure 8 Activity of raf and MAP kinases after serum withdrawal. J2E cells were deprived of serum and the activity of raf (black histogram) determined over 6 h. The phosphorylation status of p42 (hatched histogram) and p44 (stippled histogram) MAP kinases was followed for the same time period. 
c-jun increases during apoptosis
Changes to a number of cell cycle proteins and transcription factors molecules have been associated with apoptosis. The following molecules were investigated to determine if they changed during programmed cell death of J2E cells and whether epo would reverse these effects: cdc 2 (p34), cdk 2, cdk 4, cdk 5, proliferating cell nuclear antigen (PCNA), cyclin A, cyclin B1, cyclins D1-D3, cdc 25, fos, jun and myc. Most of the proteins did not alter after withdrawal of serum. However, cyclin B1 showed a transient increase which was not influenced by epo, and cyclin D3 underwent a brief elevation upon epo stimulation. In contrast, c-jun protein content rose appreciably within cells deprived of FCS (Figure 10 ). Similar increases in c-jun were observed when J2E cultures were overgrown and underwent apoptosis (data not shown). Increases in c-jun have been associated with the genesis of cell death in a number of cell systems (Colotta et al, 1992; Estus et al, 1994; Goldstone and Lavin, 1994) . While epo could reduce death of J2E cells, it did not suppress the rise in c-jun (Figure 10 ). To determine if c-jun was involved in the apoptotic process, anti-sense oligonucleotides to the transcription factor were added to J2E cultures. However, inhibiting c-jun had no effect on apoptosis or the maintenance of viability promoted by epo (data not shown). We concluded that the rise in c-jun may not necessarily be responsible for cell death in J2E cells.
Discussion
J2E cells die rapidly when serum is withdrawn, bearing the hallmarks of apoptosis (Kerr et al, 1972; Wyllie et al, 1980; Raff, 1992) . Microscopic analyses revealed nuclear condensation and fragmentation, reduced cell volume and condensed membrane-bound organelles. Nuclear disruption was associated with extensive DNA breakdown as evidenced by the increased number of cells with less than diploid DNA content, and the emergence of oligonucleosomal banding patterns. Commitment to cell death occurred 4 h after FCS withdrawal and significant loss in viability was seen thereafter. Similar effects have been observed in numerous haemopoietic systems after growth factor depletion e.g. when epo is withdrawn from Friend virus-infected erythroblasts and HCD-57 cells Bondurant 1988, 1990; Spivak et al, 1991) , and when IL-3, GM ± CSF or granulocyte colony stimulating-factor (G ± CSF) is removed from myelomonocytic FDCP cells (Williams et al, 1990) .
Epo was able to protect J2E cells from apoptosis caused by serum depletion ± viability of the cells was maintained and DNA breakdown reduced substantially. Several other factors were unable to prevent the inexorable progression to death. These results support the proposition that epo has the capacity to promote survival of erythroid precursor cells Bondurant, 1988, 1990; Spivak et al, 1991) . However, Friend virus-infected erythroblasts are heterogenous in their susceptibility to apoptosis, and DNA breakdown is inhibited over a wide range of epo concentrations (Kelley et al, 1993) , whereas the clonal J2E line responds to epo over the narrow dose response range that also initiates cellular maturation (Busfield and Klinken, 1992) . Interestingly, apoptosis of erythroblasts deprived of epo can occur at any stage of the cell cycle (Kelley et al, 1994 ).
JAK2 appears to be intimately involved in the survival signal transmitted by epo. Suppression of JAK2 with antisense olignucleotides not only prevented proliferation and differentiation of J2E cells (Tilbrook et al, 1996b) , but also restricted the maintenance of viability by epo (Table 2) . This result is compatible with the data of Zhuang et al (1995) , who noted that JAK2 was involved in epo signalling for maintaining viability in myeloid FDCP-1 cells transfected with epo receptor and JAK2 constructs. Our studies extend their observations to show the involvement of JAK2 with epo-induced viability in an erythroid cell line. Both studies suggest that phosphorylation of the receptor via JAK2 may play an important role in viability signalling, or alternatively, JAK2 has some direct role in supporting survival. It is noteworthy that JAK2 can be activated in a mutant clone of J2E cells (J2E-NR) which does not proliferate or differentiate in response to epo, but does remain alive when epo is present (Tilbrook et al, 1996a) . The role of STATs in JAK2 signalling in erythroid cells is unclear at present. There have been numerous reports on epo activating STATs (Damen et al, 1995; Penta and Sawyer, 1995; Quelle et al, 1996; Ohashi et al, 1995; Gouilleux et al, 1995; Tilbrook et al, 1996b ) but whether they participate in proliferation, differentiation or viability remains to be determined.
The commitment to programmed cell death in J2E cells also occurred whenever the cells' capacity to divide was restricted. Attainment of confluence, exposure to aphidicolin and withdrawal of FCS were all associated with reduced cell division and subsequent apoptosis. This susceptibility of J2E cells to apoptosis may be linked with dysregulation of the myc gene, as the cells contain an aberrant v-myc in the J2 virus (Klinken et al, 1988) . Constitutive expression of c-myc in fibroblasts and IL-3, or epo-, dependent myeloid cells has been shown to promote cell death when proliferation is blocked (Evan et al, 1992; Shi et al, 1992; Askew et al, 1991) . It has been postulated that c-myc induces mitosis when activated in conjunction with another growth signal; in the absence of the secondary signal, mycmediated cell death occurs (Harrington et al, 1994) . Clearly there are factors present in FCS which provide additional signals for proliferation of J2E cells ± if these are removed, or cell division is inhibited by other means, the J2E cells die. However, in contrast with the data presented here, Askew et al (1993) observed that epo was unable to prevent apoptosis in 32D myeloid cells inappropriately expressing c-myc. The J2E erythroid cells were far more susceptible to apoptosis than MEL cells which are immortalized at a similar stage of erythroid development (Marks and Rifkind, 1978) . The difference in viability between these cell lines is consistent with aberrant myc expression in J2E, but not MEL cells. Significantly, J2E cells could be protected from cell death by epo, whereas MEL cells were not. This inability could reflect binding of the viral gp55 protein to the epo receptor in MEL cells (Li et al, 1990) , or result from the severe truncation to the cytoplasmic domain of the receptor that we have observed recently (Bittorf et al, 1996) . Therefore, in addition to being unable to differentiate or proliferate in response to epo, MEL cells are incapable of transducing any epo-initiated viability signals.
J2E cells also constitutively express the v-raf oncogene and it has been suggested that raf may suppress apoptosis (Cleveland et al, 1994) , possibly via a link with bcl2 (Wang et al, 1994) . In this case raf appears to provide little protection from rapid cell death ± perhaps the effect of myc on apoptosis is dominant over raf? As raf is upstream of MAP kinase in the phosphorylation cascade, it was not surprising to observe that the MAP kinases were highly phosphorylated in J2E cells. However, with serum deprivation raf kinase activity remained unaltered, while MAP kinase activation fell precipitously. There appear to be two explanations for this phenomenon: (i) v-raf is not entirely responsible for the phosphorylation status of MAP kinases in J2E cells and serum factors also contribute to its activation, (ii) a phosphatase (perhaps a MAP kinase specific phosphatase) is stimulated with FCS depletion. Although MAP kinases could be partially re-activated by FCS, serum factors are also mitogenic and it is conceivable that the phosphorylation of MAP kinases is related to intracellular signalling for proliferation, rather than for maintaining viability. Two pieces of evidence support the concept that the MAP kinase pathway is associated with proliferation and differentiation, but not survival. First, J2E-NR cells remain alive in the presence of the epo and MAP kinases are not activated (Tilbrook et al, 1996a) . Second, down-regulation of MAP kinases with anti-sense oligonucleotides had no effect on epo-stimulated viability of J2E cells (Table 3 ). The data agree with the observation that vabl suppression of apoptosis is independent of MAP kinase activation (Owen-Lynch et al, 1995) .
Materials and Methods
Cell culture J2E cells (Klinken et al, 1988) and MEL cell line, F4N (Dube et al, 1975) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS. Recombinant growth factors used in these studies were: 10 U/ml human epo (Eprex; Janssen-Cilag, Sydney, Australia), 100 U/ml SCF (a gift from Dr P Steinlein, Institute for Molecular Pathology, Vienna, Austria), 100 U/ml IL-3 and GM ± CSF (gifts from Dr Nicos Nicola, Walter and Eliza Hall Institute, Melbourne, Australia), 100 U/ml insulin (Commonwealth Serum Laboratories, Melbourne, Australia), 100 U/ml IGF-1 and 100 U/ml growth hormone (gifts from Dr G Werther, Royal Children's Hospital, Melbourne, Australia). Aphidicolin (Sigma, St Louis, Mo, USA) was used at a final concentration of 2.5 mM.
Cytocentrifuge preparations and electron microscopy
Cells were cytocentrifuged at 300 rpm for 5 min onto glass slides using a cytospin 2 (Shandon, Cheshire, UK) and fixed with methanol. May-Grunwald-Geimsa stain (BDH, Poole, England), bisbenzimide H33258 (Calbiochem-Novabiochem, San Diego, CA, USA) or acridine orange (Sigma, St Louis, MO, USA) were placed on the slides for 5 min, washed in Sorenson's buffer (66 mM Na 2 HPO 4 , 66 mM KH 2 PO 4 ) and then viewed with either a Zeiss light microscope or a Leitz Ortholux 2 fluorescence microscope and photographed with a Leitz Orthomat 2 camera. Cell viability was determined by exclusion of 0.4% eosin as viewed on a haemocytometer (Klinken et al, 1988; Busfield and Klinken, 1992) , while differentiation was quantitated by benzidine staining of haemoglobin producing cells (Cooper et al, 1974) . Apotag was purchased from ONCOR (Gaithersberg, MD, USA). For ultrastructural analyses cells were fixed in 2.5% paraformaldehyde/2.5% glutaraldehyde, sectioned, stained with uranylacerate and viewed under a Philips 410 electron microscope as described previously (Busfield et al, 1993c) .
Cell cycle analysis and [ 3 H]-thymidine incorporation
Cells were prepared for cycle analysis by adding 0.25% Triton X-100 and 250 mM propidium iodide to 10 6 cells. The stained nuclei were then analyzed on a FACScan II unit (Becton Dickinson, Mountain View, CA, USA) and the proportion of cells in each phase of the cell cycle calculated (Busfield and Klinken, 1992) . To measure DNA synthesis 0.5 mCi [ 3 H]-thymidine (25 mCi/mmol [methyl-3 H]-thymidine; Amersham, Bucks, UK) was added to 5610 4 cells for 6 h. DNA was then collected onto glass fibre filters (Whatman, Kent, UK) using a microharvester (Skatron, Lier, Norway) and incorporation of labelled nucleotide measured by scintillation counting in a Beckman LS 6800 counter (Busfield and Klinken, 1992) .
Data analysis
DNA integrity was assessed by a modification of the method of Strange et al (1992) as used by us previously (Tilbrook et al, 1996a) . Cells were pelleted, lysed with 6 M guanidine hydrochloride (BRL Life Technologies, MD, USA) and nucleic acids precipitated with ethanol. The pellet was then resuspended in 10 mM Tris, 10 mM EDTA, 10 mM NaCl, 0.5% SDS. 0.2 mg/ml proteinase K and incubated at 508C overnight. After phenol/chloroform extraction and ethanol precipitation the pellet was resuspended in 10 mM Tris, 1 mM EDTA 20 mg/ml RNase A (Sigma) and incubated at 378C for 1 h. The DNA content was determined by staining with bisbenzimide H 33258 (CalbiochemNovabiochem), according to the method of Labraco and Paigen (1980) , before 7.5 mg of each sample was separated through a 1% agarose gel.
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Protein analysis
J2E cells were washed three times in DMEM and resuspended at 2 ± 5610 5 cells/ml DMEM. For MAP kinases analysis, cells were incubated for up to 5 h before re-addition of 10% FCS for 30 min. For transcription factor and cell cycle protein analyses, cells were incubated for up to 24 h in the presence or absence of epo (5 U/ml). Cells were lysed and proteins analysed by immunoblotting with anti-MAP kinase (Erk 1), jun, fos, myc, cdc 2(p34), cdk2, cdk4, cdk5, PCNA, cyclins A 1 , B 1 , D 1 , D 2 , D 3 , and cdc 25 antibodies (Santa Cruz Biotechnology, CA, USA) as described previously (Busfield et al, 1995a,b; Callus et al, 1995; Tilbrook et al, 1996a,b) .
Raf activity J2E cells were washed three times in DMEM, resuspended at 2610 6 / ml and incubated for up to 6 h in DMEM without serum. Cells were lysed and 1 mg protein immuno-precipitated with anti-raf antibody (Santa Cruz Biotechnology) as described previously (Busfield et al, 1995a; Tilbrook et al, 1996a,b) . The immunoprecipitates were washed in kinase buffer (25 mM HEPES pH 7.4, 25 mM b-glycerol phosphate, 1 mM DTT, 10 mM MgCl 2 ), resuspended in 100 ml kinase buffer with 20 mCi [ 32 P]gATP (Amersham), 0.1 mM ATP and either 20 mg Syntide (Santa Cruz Biotechnology) or 200 mg myelin basic protein (Sigma) for 20 min at 308C. The reaction was terminated by addition of 16Laemelli buffer, the samples were then separated on an 8 ± 25% gradient gel, which was later dried and exposed to X-ray film. Incorporation of [ 32 P]gATP into the substrate was quantitated densitometrically.
Anti-sense oligonucleotide protocols
Phosphorothioate modified oligonucleotides were purchased from Macromolecular Resources (CO, USA) and Biognostik (Go È ttingen, Germany). Anti-sense oligo-nucleotides were generated to JAK2 (5'-GCT TGT GAG AAA GC-3'), p42 and p44 MAP kinases (5'-GCC GCC GCC GCC GCC AT-3') and c-jun (5'-CGT TTC CAT CTT TGC AGT-3') as described previously (Tilbrook et al, 1996b; Sale et al, 1995; Soprano et al, 1992) . The random/scrambled oligonucleotides were 5'-GTC CCT ATA CGA AC-3' (Tilbrook et al, 1996b) , 5'-CGC GCG CTC GCG CAC CC-3' (Sale et al, 1995) and 5'-CGT GTC AAT AAT GGC AGT-3' (Soprano et al, 1992) . J2E cells were established at 5610 4 cells/ml and incubated with 2 ± 10 mM oligonucleotide for three days; cultures were diluted to 5610 4 cells/ml daily and the oligonucleotide replenished. Cells were then washed three times in DMEM, replated at 3 ± 5610 5 cells/ml with 2 ± 10 mM oligonucleotide and epo (5 U/ml). Cultures were maintained for a further 24 ± 48 h and the oligonucleotide was replenished after 24 h. Protein levels were analysed by Western blots and quantitated by densitometry. Statistical significance was demonstrated by students t-test where a P value of 50.05 was considered significant.
